Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional implications of SNPs in spliceosomal network: a structural systems biology approach. | J Biomol Struct Dyn | 2026 | 42343645 | PubTator, text mining | PubMed |
| Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation. | Hematol Oncol | 2026 | 42313655 | PubTator, text mining | PubMed |
| Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience. | Ann Hematol | 2026 | 42249961 | PubTator, text mining | PubMed |
| Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS. | bioRxiv | 2026 | 42239263 | PubTator, text mining | PubMed |
| Divergent RNA structures support accurate splicing of the SF3B1-sensitive MAP3K7 intron. | bioRxiv | 2026 | 42239186 | PubTator, text mining | PubMed |
| Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective study. | Hematology | 2026 | 42237068 | PubTator, text mining | PubMed |
| [Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227434 | PubTator, text mining | PubMed |
| The competition between splicing and 3' processing shapes the human transcriptome. | Genes Dev | 2026 | 42140670 | PubTator, text mining | PubMed |
| Leukemia Cutis at Initial Diagnosis of Acute Myeloid Leukemia Consistent With Therapy-Related Disease After Lung Cancer Chemotherapy: A Case Report. | Case Rep Hematol | 2026 | 42112411 | PubTator, text mining | PubMed |
| Cold Agglutinin-Mediated Hemolytic Anemia Preceding the Diagnosis of Acute Myeloid Leukemia: A Case Report and Literature Review. | Cureus | 2026 | 42110104 | PubTator, text mining | PubMed |
| Long-term (74-month) efficacy and safety of ivosidenib and azacitidine in an elderly patient with mutated IDH1 acute myeloid leukemia: insights from a case report. | Postgrad Med | 2026 | 42108620 | PubTator, text mining | PubMed |
| A single-cell solution to a transplant mystery. | Med | 2026 | 42105743 | PubTator, text mining | PubMed |
| Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. | Blood Adv | 2026 | 42101375 | PubTator, text mining | PubMed |
| U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice. | Leukemia | 2026 | 42092046 | PubTator, text mining | PubMed |
| Evaluating splicing factor and kinase network crosstalk through global phosphoproteomics. | bioRxiv | 2026 | 42079238 | PubTator, text mining | PubMed |
| Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia. | NEJM Evid | 2026 | 42047559 | PubTator, text mining | PubMed |
| One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. | Blood Cancer J | 2026 | 41935083 | PubTator, text mining | PubMed |
| U2AF regulates the translation and localization of nuclear-encoded mitochondrial mRNAs. | Mol Cell | 2026 | 41932309 | PubTator, text mining | PubMed |
Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature. | Ann Hematol | 2026 | 41925752 | PubTator, text mining | PubMed |
| Medulloblastoma in Adolescents and Young Adults: Molecular Subgroups, Prognostic Biomarkers, and Age-Specific Therapeutic Challenges. | Curr Issues Mol Biol | 2026 | 41899451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=2